HCAIX | VIGAX | HCAIX / VIGAX | |
Total Expense Ratio | 1.02 | 0.05 | 2,040% |
Annual Report Gross Expense Ratio | 1.07 | 0.05 | 2,140% |
Fund Existence | 23 years | 25 years | - |
Gain YTD | -5.546 | -6.235 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.5B | 269B | 9% |
Annual Yield % from dividends | 0.00 | 0.50 | - |
Returns for 1 year | -1.80 | 12.27 | -15% |
Returns for 3 years | 54.08 | 64.13 | 84% |
Returns for 5 years | 28.58 | 107.94 | 26% |
Returns for 10 years | 57.87 | 255.69 | 23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FMAY | 46.31 | 0.23 | +0.51% |
FT Vest US Equity Buffer ETF May | |||
PIZ | 42.48 | 0.04 | +0.09% |
Invesco DW Developed Markets Momt ETF | |||
BBP | 55.01 | -0.07 | -0.13% |
Virtus LifeSci Biotech Products ETF | |||
AVEM | 61.66 | -0.13 | -0.21% |
Avantis Emerging Markets Equity ETF | |||
IFGL | 21.48 | -0.07 | -0.32% |
iShares International Dev Real Est ETF |